Total medical devices industry M&A deals worth $861.84m were announced globally in February 2021, led by Veracyte’s $600m acquisition of Decipher Biosciences, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 96.4% over the previous month of $24.1bn and a drop of 88.4% when compared with the last 12-month average, which stood at $7.43bn.
Comparing M&A deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $831.84m. At the country level, the US topped the list in terms of deal value at $831.84m.
In terms of volumes, North America emerged as the top region for medical devices industry M&A deals globally, followed by Europe and then Asia-Pacific.
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below formBy GlobalData
The top country in terms of M&A deals activity in February 2021 was the US with 28 deals, followed by the Canada with four and Germany with two.
In 2021, as of February, medical devices M&A deals worth $24.96bn were announced globally, marking an increase of 1041.3% year on year.
medical devices industry M&A deals in February 2021: Top deals
The top five M&A deals accounted for 97.04% of the overall value during February 2021.
The combined value of the top five medical devices M&A deals stood at $836.34m, against the overall value of $861.84m recorded for the month.
The top five medical devices industry M&A deals of February 2021 tracked by GlobalData were:
1) Veracyte’s $600m acquisition of Decipher Biosciences
2) The $150m acquisition of Simplify Medical by NuVasive
3) Mind Medicine MindMed’s $32.66m acquisition of HealthMode
4) The $30m asset transaction with Earlysense by Hill-Rom Holdings
5) OncoCyte’s acquisition of Chronix Biomedical for $23.68m.